Terms: = Liver cancer AND MSN, P26038, 4478, ENSG00000147065 AND Prognosis
4 results:
1. PEG-grafted arsenic trioxide-loaded mesoporous silica nanoparticles endowed with pH-triggered delivery for liver cancer therapy.
Jiang L; Wang X; Raza F; Zhong H; Su J; Yuan WE; Qiu M
Biomater Sci; 2023 Jul; 11(15):5301-5319. PubMed ID: 37357799
[TBL] [Abstract] [Full Text] [Related]
2. Identification of potential biomarkers of peripheral blood mononuclear cell in hepatocellular carcinoma using bioinformatic analysis: A protocol for systematic review and meta-analysis.
Peng JL; Wu JZ; Li GJ; Wu JL; Xi YM; Li XQ; Wang L
Medicine (Baltimore); 2021 Jan; 100(2):e24172. PubMed ID: 33466191
[TBL] [Abstract] [Full Text] [Related]
3. Application of Abdominal Imaging Based on Nano Drug Delivery System for Diagnosis and Treatment of liver cancer.
Fan Z; Liu Q; Lu F; Dong Z; Gao P
J Nanosci Nanotechnol; 2021 Feb; 21(2):824-832. PubMed ID: 33183413
[TBL] [Abstract] [Full Text] [Related]
4. Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence.
Zhang F; Jia Y; Zheng X; Shao D; Zhao Y; Wang Z; Dawulieti J; Liu W; Sun M; Sun W; Pan Y; Cui L; Wang Y; He K; Zhang M; Li J; Dong WF; Chen L
Acta Biomater; 2019 Dec; 100():352-364. PubMed ID: 31563690
[TBL] [Abstract] [Full Text] [Related]
